When increased prostaglandin synthesis was induced in anesthetized cats equipped with cranial windows by topical application of arachidonate (200 Mg/ml) or bradykinin (20 /xg/ ml), there was reduction of nitroblue terrazolium, resulting in deposition of the reduced insoluble form of this dye on the brain surface. The amount of reduced nitroblue terrazolium deposited on the brain surface was measured spectrophotometrically after fixation of the brain by perfusion with aldehydes to eliminate interference from hemoglobin. Topical application of 56 U/ml superoxide dismutase or 20 Mg/mJ indomethacin inhibited nitroblue terrazolium reduction by 76.5%-82.5% and by 78%-85.5%, respectively. These results show that most of the nitroblue terrazolium reduction was accounted for by superoxide anion radical generated in the course of arachidonate metabolism via the cyclooxygenase pathway. No superoxide production could be detected in the absence of arachidonate or bradykinin. Histological examination showed no evidence of parenchymal cellular damage or vascular damage and no accumulation of leukocytes. Pronounced leukocyte accumulation occurred 24 hours after topical arachidonate in rabbits with chronically implanted cranial windows. Superoxide appearance was reduced severely by 4,4'diisothiocyano-2,2'-stilbene disulfonate and phenylglyoxal, two specific inhibitors of the anion channel. The most likely explanation for these findings is that increased metabolism of exogenous or endogenous arachidonate via cyclooxygenase results in the appearance of superoxide anion radical in cerebral extracellular space. Superoxide crosses the membrane of undamaged cells via the anion channel. (Circ Res 57:142-151, 1985) 
SUMMARY. When increased prostaglandin synthesis was induced in anesthetized cats equipped with cranial windows by topical application of arachidonate (200 Mg/ml) or bradykinin (20 /xg/ ml), there was reduction of nitroblue terrazolium, resulting in deposition of the reduced insoluble form of this dye on the brain surface. The amount of reduced nitroblue terrazolium deposited on the brain surface was measured spectrophotometrically after fixation of the brain by perfusion with aldehydes to eliminate interference from hemoglobin. Topical application of 56 U/ml superoxide dismutase or 20 Mg/mJ indomethacin inhibited nitroblue terrazolium reduction by 76.5%-82.5% and by 78%-85.5%, respectively. These results show that most of the nitroblue terrazolium reduction was accounted for by superoxide anion radical generated in the course of arachidonate metabolism via the cyclooxygenase pathway. No superoxide production could be detected in the absence of arachidonate or bradykinin. Histological examination showed no evidence of parenchymal cellular damage or vascular damage and no accumulation of leukocytes. Pronounced leukocyte accumulation occurred 24 hours after topical arachidonate in rabbits with chronically implanted cranial windows. Superoxide appearance was reduced severely by 4,4'diisothiocyano-2,2'-stilbene disulfonate and phenylglyoxal, two specific inhibitors of the anion channel. The most likely explanation for these findings is that increased metabolism of exogenous or endogenous arachidonate via cyclooxygenase results in the appearance of superoxide anion radical in cerebral extracellular space. Superoxide crosses the membrane of undamaged cells via the anion channel. (Circ Res 57:142-151, 1985) IN EARLIER experiments Kontos et al., 1981) , we showed that vascular abnormalities seen in pial arterioles of cats after experimental fluid-percussion brain injury, or after acute severe hypertension, were inhibited by pre.treatment with cyclooxygenase inhibitors or by topical application of free radical scavengers. These results suggested that the vascular abnormalities seen in these conditions were mediated by oxygen radicals generated in the course of increased prostaglandin synthesis. Consistent with this hypothesis are the findings of activation of phospholipase C (Wei et al., 1982) and of increased prostaglandin concentration in brain tissue after brain injury, and the demonstration that similar vascular abnormalities could be produced by topical application of arachidonate or prostaglandin endoperoxide G 2 (PGG 2 ) . The effects of arachidonate were minimized by inhibition of cyclooxygenase, and the effects of arachidonate or PGG2 were inhibited by oxygen radical scavengers . One of the free radical scavengers used, superoxide dismutase (SOD), is an enzyme with high molecular weight and, hence, is not likely to enter cells readily. Its effectiveness under these ex-perimental conditions implied that superoxide anion radical must enter the extracellular space. The present experiments were undertaken to demonstrate directly the presence of superoxide anion radical in cerebral extracellular space during increased prostaglandin synthesis induced by arachidonate or by bradykinin.
Methods

Preparation of Animals
Experiments were carried out in cats, dogs, and in rabbits. The cats and dogs were anesthetized with sodium pentobarbital (30 mg/kg, iv). After tracheostomy, each animal was ventilated with a positive pressure respirator and received 5 mg/kg of gallamine triethiodide iv for skeletal muscle paralysis. The end-expiratory CO 2 of the animals was continuously monitored with a Beckman infrared CO2 analyzer and was maintained at a constant level of about 30 mm Hg. Arterial blood pressure was measured with a Statham pressure transducer connected to a cannula introduced into the aorta via the femoral artery. Arterial blood samples were collected for determination of arterial blood oxygen and CO2 partial pressures (Pach and Pacch, respectively), pH, and hematocrit at appropriate intervals during the experiment. Blood gas tensions and pH were measured with Radiometer elec-trodes. Hematocrit was measured by a micromethod. A double cranial window technique was employed in cats and dogs. A cranial window was acutely implanted into the skuU caudal to the coronal suture over the ectosylvian and suprasylvian gyri of each hemisphere. The cranial window technique used here was otherwise identical to the single window technique described in detail previously (Levasseur et al., 1975) . The space under the window was filled with artificial cerebrospinal fluid (CSF) identical in composition to that of CSF of cats or dogs (Davson, 1967) .
The rabbits, while under pentobarbital anesthesia, were implanted 2 weeks earlier with a plastic cranial window described in detail previously (Levasseur et al., 1975) . This window is suitable for the repeated observation of the surface microcirculation of the brain over a period of several months. The rabbits were trained to lie quietly under a microscope, and were studied unanesthetized. The caliber of cerebral arteries in these animals was measured with a Vickers image-splitting device attached to a Leitz Ultropak microscope with the aid of a TV camera and monitor as described before (Levasseur et al., 1975) . Electroencephalogram (EEG) was recorded from stainless steel screws implanted in the skull at the time of the cranial window installation.
Detection of Superoxide
Detection of superoxide anion radical relied on reduction of nitroblue tetrazolium (NBT). This is a yellow, water-soluble dye which, when reduced by superoxide anion radical or by other reducing agents, is converted to an insoluble blue form, which precipitates (Beauchamp and Fridovich, 1971 ). We used a 2.4 mM solution of NBT in CSF to fill each cranial window. Prostaglandin synthesis was stimulated by arachidonate, 200 Mg/ml CSF, or by bradykinin (triacetate salt), 20 fig/nil CSF. We prepared a 10 mg/ml sodium arachidonate stock solution (referred to as arachidonate) by dissolving three parts arachidonic acid and one part sodium carbonate (wt/wt) in distilled water. From this sodium arachidonate stock solution, 20 Y\ were added to each ml of artificial CSF to give a final concentration of 200 jig/ml. Superoxide dismutase (SOD) (from bovine blood, 2,800 U/mg protein), 20 jig/ml CSF, was used to scavenge the superoxide anion radical and indomethacin, 20 //g/ml CSF, was used to induce cyclooxygenase blockade. A 10 mg/ml stock solution of the sodium salt of indomethacin was prepared fresh daily by dissolving three parts indomethacin and one part sodium carbonate (wt/wt) in distilled water. From this stock solution, 20 fi\ were added to each ml of CSF to give a final concentration of 20 Mg/ml. If necessary, the final pH of all solutions in CSF was adjusted to 7.35.
The experimental protocol was as follows. In experiments in which arachidonate was used, one cranial window was filled with CSF containing NBT plus arachidonate, while the window on the contralateral side was filled with NBT plus arachidonate and either indomethacin or SOD. A similar protocol was used for the bradykinin experiments except that bradykinin was substituted for arachidonate. These solutions were left in contact with the brain for 12-35 minutes. The reduction of NBT was terminated by washing the excess NBT from the space under the window with fresh CSF not containing any additives. Subsequently, the brain was fixed by perfusion. For this purpose, a catheter was placed into the left atrium via a thoracotomy and the brain was perfused first with 0.9% NaCl solution and then with a mixture of 2.5% glutaral-143 dehyde and 2% paraformaldehyde in 0.1 M phosphate buffer. Fixation by perfusion was used to eliminate red cells from the field reliably, because hemoglobin absorbs light in the same wavelength region as NBT. Since changes in blood volume might be anticipated as a result of the interventions used, the interpretation of any color changes might be complicated in the presence of hemoglobin. After fixation was completed, the brain was removed from the cranial cavity and the amounts of NBT deposited were determined spectrophotometrically. We used a modified Perkin-Elmer double-beam model 124 spectrophotometer equipped with a 3-mm diameter fiberoptics light guide which transmitted the incident and reflected light to and from the brain surface. The area of the brain corresponding to the cranial window, which has a diameter of 12 mm, was divided into four quadrants. Absorbance readings were taken at the appropriate wavelengths from each of these four quadrants. We used a two-wavelength technique. The two wavelengths chosen were 570 and 450 nm. The 570-nm wavelength was chosen to be at the peak of the absorption spectrum of reduced NBT. The 450-nm wavelength was chosen by trial and error in such a way that the variation in absorbance difference at 570 and 450 nm from one region of the brain to the other and from one brain to the next was as small as possible. In 99 such determinations of this difference of absorbance in the absence of NBT deposition in 20 animals, the standard error was 0.7% of the mean absorbance difference.
Calibration was achieved by depositing known amounts of NBT on the brain surface by reduction of the dye with superoxide anion radical generated via the xanthine oxidase reaction (Beauchamp and Fridovich, 1971) . For this purpose, 0.01-0.1 /ig/ml xanthine oxidase (from buttermilk 0.9 U/mg protein) and 0.1 mM xanthine, together with NBT, 0.5-4 mM, were placed in the space under the cranial windows in four cats. The reaction was allowed to proceed for varying periods. The brain was subsequently fixed by perfusion as described above for the experiments using arachidonate or bradykinin.
After the surface spectrophotometric determinations were completed, the amount of reduced NBT deposited on the brain surface was extracted and measured as follows (Rajagopalan and Handler, 1964; Baehner and Nathan, 1968; Chan and Fishman, 1980) : The brain tissue corresponding to the area under the cranial windows was removed with a cork borer, whose diameter equaled the diameter of the window. A similar sample of normal brain tissue from an adjacent area was also removed and processed to serve as a blank in the spectrophotometric assays. The cylinder of brain tissue were then trimmed to a disk approximately 1.5 mm thick to ensure the removal of all NBT without an excessive amount of underlying brain tissue. The brain samples were then minced, homogenized in 0.9% NaCl solution, and spun in a polypropylene centrifuge tube at 10,000 g for 10 minutes. The supernatant was removed and the pellet was resuspended in 5 ml of reagent grade pyridine. The resultant homogenate was placed in an 85°C vortex heating block for 1 hour. The tubes then were centrifuged at 10,000 g for 10 minutes and the supernatant was removed. Pyridine was evaporated with nitrogen and the reduced NBTcontaining residue was redissolved in 3.5 ml of pyridine. The tubes were again spun at 10,000 g for 10 minutes to remove microparticulate matter. Three-milliliter portions of the solution were carefully removed and read spectrophotometrically at 515 nm with a Beckman model 34 Circulation Research/Vo/. 57, No. 1, July 1985 spectrophotometer. Final concentrations were expressed in nm/cm 2 brain surface area to provide suitable correlations with the surface spectrophotometric data.
Histological Studies
Histological studies of the brains of additional animals were carried out for several purposes. To detect the location of the NBT deposits, routine histological examination was conducted. For this purpose, the brain was removed, blocked to include the area under the cranial window, and then sectioned with a vibratome at a thickness of 300 nm in a plane perpendicular to the cortical surface. After dehydration in ascending grades of ethanol, the sections were cleared in xylene, mounted on glass slides, and photographed at a suitable magnification without additional staining.
To study the morphological integrity of the brain parenchyma after fixation we removed other brains and blocked out the regions underlying the cranial windows for subsequent ultrastructural examination. These tissue blocks were serially sectioned at a thickness of 40 iim on a vibratome. The sections were then osmicated, dehydrated, and embedded in Medcast resin on plastic slides. The region underlying the window was identified in the plastic-embedded material, dissected free, and transferred to plastic studs (Povlishock et al., 1983) . Thin sections were cut on an ultramicrotome with a diamond knife and picked up on 200 mesh grids. After staining with uranyl acetate and lead citrate, the thin sections were viewed and photographed on an electron microscope.
Additional studies of the integrity of brain neurons were also accomplished by studying the ability of neurons to exclude bulk inundation by extracellularly applied horseradish peroxidase. For this purpose, 50 mg of horseradish peroxidase (Sigma Type IV) dissolved in 0.5 ml of artificial CSF were applied to the cerebral cortex underlying each cranial window after application of arachidonate or bradykinin. One hour after the application of the peroxidase, the animal was transcardially perfused with a fixative composed of 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M phosphate buffer. The brain was removed and the regions underlying the cranial windows were blocked out for subsequent histological analysis. These tissue blocks were then serially sectioned at a thickness of 40 urn on a vibratome. The serial sections were collected in the ordered compartments of divided plastic trays, with adjacent serial sections being reacted for the visualization of the protein reaction product through the use of either the tetramethylbenzidine (TMB) technique (Mesulam, 1983) or the cobalt-glucose oxidase method (Itoh et al., 1979) . Sections prepared with the TMB method were dehydrated, cleared, and mounted on glass slides, while sections prepared by the cobalt-glucose oxidase method were osmicated, dehydrated, and embedded in Medcast resin on plastic slides from which thick sections were cut with glass knives on an ultramicrotome. All sections so obtained were subjected to routine light microscopic analyses.
Concurrent comparisons were made with sections of brain samples obtained from the site of impact in animals subjected to fluid percussion brain injury . Neurons from this site regularly display cell change with concomitant peroxidase inundation.
The morphology of pial arterioles was studied by scanning and transmission electron microscopy. The technique for obtaining the pial arterioles from the site of the cranial window for such studies has been described previously in detail .
Anion Channel Inhibition
It is known that the exchange of monovalent anions through cell membranes is mediated by a large transmembrane protein known as band 3 protein (Wieth et al., 1982a) . Several chemically unrelated inhibitors of the anion channel are known. We used 4,4'-diisothiocyano-2,2'-stilbene disulfonate (DIDS) and phenylglyoxal. DIDS in a concentration of 100 HM was placed together with NBT under one cranial window while the opposite cranial window contained only NBT. Increased prostaglandin synthesis was induced by bradykinin placed in a concentration of 20 nfJrrA in ea ch window. DIDS is a reversible specific inhibitor of the anion channel (Cabantchik and Rothstein, 1974) . Phenylglyoxal is known to inhibit the anion channel irreversibly after only a very brief exposure at high pH, presumably by modifying arginine residues in the transport protein (Wieth et al., 1982b) . We first treated one window site with a solution of phenylglyoxal of 20 DIM for 2 minutes at pH 10. After washout with fresh CSF, the two windows were filled with CSF containing NBT and bradykinin and the experiment proceeded in the usual manner.
To exclude the possibility that the anion channel blockers we used reduced prostaglandin synthesis, we tested their effects on platelet aggregation induced by arachidonate. Human blood was collected into sodium citrate solution and washed platelets were prepared (Hamberg et al., 1974) . Aliquots of washed platelets were placed in an aggregometer and stimulated to aggregate with sodium arachidonate (final concentration, 100 jig/ml). This aggregation was consistently inhibited by pretreatment of the platelets with 3 Mg/ml of indomethacdn. We tested the effects of DIDS and phenylglyoxal by pretreating the platelets for 3 minutes with each of these agents before adding arachidonate. Neither DIDS nor phenylglyoxal inhibited platelet aggregation.
Experiments in Neutropenic Animals
To study further the contribution of neutrophils in the production of superoxide, we administered specific sheep antiserum directed against canine neutrophils in four dogs and three cats. The antibody was obtained from Drs. S.L. Kunkel and B.R. Lucchesi, Departments of Pathology and Pharmacology, University of Michigan. It was prepared by inoculating sheep with purified canine neutrophil suspension, as described before for the preparation of rabbit neutrophil antiserum (Romson et al., 1983) . The animals received an initial dose of 4 ml of antiserum, given slowly into the femoral vein. Subsequently, a second and third injection of 2 ml of antiserum were administered at 60 and 90 minutes after the initial injection. Blood samples for total leukocyte and neutrophil counts were obtained before the first injection of antiserum and 2 hours after the first injection. Subsequently, superoxide production in response to topical application of bradykinin was studied.
In Vitro Measurement of Superoxide Production
The rate of production of superoxide from the xanthine oxidase reaction or from human leukocytes activated with phorbol myristate acetate was measured spectrophotometrically as the SOD-inhibitable portion of the reduction of ferricytochrome c or NBT. The preparation and activa-tion of human leukocytes have been described previously (Rowe et al., 1983) . The specrrophotometric measurements were carried out in a Hitachi 110 A dual beam recording spectrophotometer. AJ1 assays were carried out at 37°C, pH 7.1. For the superoxide production by the xanthine oxidase reaction, we used a concentration of 0.04 U/ml of xanthine oxidase and 0.1 mM xanthine as substrate. Absorbances were measured in the presence of 30 U/ml of SOD and in its absence. The indicators were either ferricytochrome c or NBT in a concentration of 20 fiM. The initial rate of reduction of NBT was monitored at 530 nm and that of cytochrome c at 550 nm. Extinction coefficients were 21.4 X 10 3 M/cm for cytochrome c and 17.9 X 10 3 M/cm for NBT. The initial rate of production of superoxide from leukocytes was measured using a concentration of 20 /iM ferricytochrome c or NBT as described above in the presence and absence of 30 U/ml of SOD. The leukocyte concentration was 4 million/ml. Superoxide production rates by the xanthine oxidase reaction or by leukocytes measured using NBT agreed closely with rates measured using ferricytochrome c. In all instances, differences between companion measurements with the two techniques were less than 10%.
Reagents used in these experiments were obtained from the following sources: arachidonic acid from Nuchek Prep; pyridine from Pierce; bradykinin, NBT, indomethacin, DIDS, phenylglyoxal, horseradish peroxidase, ferricytochrome c, SOD, xanthine oxidase, and xanthine from Sigma; and phorbol myristate acetate from Chemicals for Cancer Research.
Results
The spectrum of the fixed brain in the absence of NBT was similar to that reported by others from blood-free brain (Wodick and Lubbers, 1974; Jobsis et al., 1977) . It showed peaks at 603, 540, and 520 nm, corresponding to the absorption peaks of cytochromes aa 3 , b, and c. No specrrophotometric evidence for the presence of hemoglobin in red cells retained in cerebral vessels was obtained. The absence of retained red cells was also verified by electron microscopy of the cerebral vessels. Figure 1 shows the relationship between the difference in absorbance at 570 and 450 nm and the amounts of NBT deposited on the brain surface by the xanthine oxidase reaction. The relationship is linear up to a concentration of 190 run/cm 2 of brain surface. This relation was used to calculate the amounts of reduced NBT from the surface specrrophotometric data. Visual examination was used to confine the duration of the experiments in such a way that the deposition of NBT was in a linear range of this relationship. Figure 2 shows a typical histological section of the portion of the brain under the cranial window showing the pattern of deposition of NBT. This pattern was similar in all experiments irrespective of whether xanthine oxidase, bradykinin, or arachidonate was used to reduce NBT. NBT deposition was confined mainly to the arachnoid and to a lesser extent to the superficial layer of the brain parenchyma. The depth of the layer of tissue in which NBT was deposited ranged from 75-125 ^m. 
FIGUM 1. Relation between the difference in absorbance at 570 and 450 nm (arbitrary units) determined by surface spectrophotometry and the concentration of reduced NBT deposited on the brain surface. The regression line, whose equation is shown in the insert, was calculated by the least square method. Since it is evident that the relation is not linear in the region of high NBT concentrations, in the regression analysis, the point at 305 nu/cm 1 was omitted.
In six cats we measured the rate of NBT reduction with and without SOD under resting conditions without stimulation of arachidonate metabolism. The rates of NBT reduction were 0.20 ± 0.09 and 0.34 ± 0.14 riM/min per cm 2 in the absence and presence of SOD, respectively. We calculated the mean rate of SOD-inhibitable NBT reduction at -0.14 ± 0.19 riM/min per cm 2 , a value not significantly different from zero.
Arachidonate induced NBT reduction in all animals tested. Figure 3 shows a typical experiment in which increased prostaglandin synthesis was induced on the right side of the brain with arachidonate, resulting in NBT reduction. NBT reduction was almost completely inhibited by the incorporation of SOD on the contralateral side. The reduction of NBT was similarly inhibited to a pronounced extent by the incorporation of indomethacin (Fig. 4) . Table 1 summarizes the results from all experiments in which increased prostaglandin synthesis was in-
FIGURE 2. Histological section of the brain at the site of deposition of reduced NBT from topical application of arachidonate. The deposition of NBT primarily in the arachnoid is evident, particularly where the latter bridges over the sulcus between gyri. FIGURE 3. Appearance of fixed brain showing deposit of reduced NBT in the right hemisphere after topical application of arachidonate. There was evident inhibition of NBT reduction by SOD and consequent absence of blue color on the left side. Reagents were left in contact with the brain for 20 minutes.
duced by topical application of arachidonate. The reduction of NBT was inhibited by 82.5 ± 4.0% by SOD and by 85.5 ± 3.7% by indomethacin. In each case, this inhibition was significantly different from zero (P < 0.001; paired f-tests). Arachidonate in a concentration of 200 ng/m\ placed in the test tube at 37°C for 30 minutes together with NBT did not cause detectable reduction of NBT. Indomethacin, 20 Mg/ml, incubated in vitro at 37°C did not change the initial rate of superoxide production by xanthine oxidase (19.6 vs. 20.9 /iM/min per U xanthine oxidase, with and without indomethacin, respectively). Table 2 shows the rate of reduction of NBT induced by bradykinin. Bradykinin caused NBT reduction in all experiments. This reduction was inhibited by 76.5 ± 10.6% by SOD and by 75 ± 9.9% by indomethacin. In each case this inhibition was significantly different from zero (P < 0.01; paired ttests). Bradykinin, 20 Mg/ml, incubated in a test tube at 37°C for 30 minutes together with NBT did not cause any detectable reduction of NBT.
We used heat-inactivated SOD to measure NBT reduction rates in four cats. NBT reduction was induced by arachidonate in two animals and by bradykinin in the other two. No inhibition of NBT reduction by the denatured SOD was detected in any of these experiments. NBT reduction rates were 3.96 ± 1.06 and 4.32 ± 1.40 nM/min per cm 2 without and with SOD, respectively. Figure 5 shows that SOD is equally effective in inhibiting NBT reduction induced by arachidonate, bradykinin, and xanthine oxidase plus xanthine.
The CSF expelled from the space under the cranial windows upon termination of the experiment had a faint blue color from suspended reduced NBT. The amount of NBT in CSF was small, and no attempt was made to quantify this portion of the NBT in all experiments.
Electron microscopic examination of the brain parenchyma under the cranial windows where arachidonate or bradykinin were applied showed no abnormalities (Fig. 6 ). Horseradish peroxidase applied topically together with arachidonate diffused into the cortical extracellular space. Despite the presence of the protein, no neuronal inundation (or flooding) with peroxidase was observed, thereby suggesting that the cortical neurons were undamaged. This contrasted with the situation seen following experimental cortical contusion, where morphologically damaged neurons were consistently Values are mean ± SE. Value for each cranial window site is the average of all readings. flooded with the protein tracer (Fig. 7) . No accumulation of leukocytes was detected in brains fixed 1 or 2 hours after arachidonate or bradykinin application. Topical application of arachidonate in awake rabbits caused no detectable change in behavior or in EEC Cerebral arterioles dilated by 14%-55% durinĝ r I 6 FIGURE 6. Panel A: this electron micrograph demonstrates the cerebral cortical surface underlying the cranial window after arachidonate application. Note that the glia limitans (arrowheads) as well as the underlying axons (A), axon terminals (T), and dendritic profiles (D), are unaltered. 15,000x. Panel B-this electron micrograph shows a cortical layer deep to that shown in panel A. The brain parenchyma exposed to topically applied arachidonate appears unremarkable. Note that the neuronal soma (NS), axons (A), and dendritic profiles (D) are unaltered. 9,000x. arachidonate application, and were still dilated 30 minutes after washout. Histological examination in two animals at this time showed no evidence of brain parenchymal damage and no leukocyte accumulation. In two animals, examination 24 hours later showed persistence of arteriolar dilation in one and return to the resting caliber in the other. Both animals displayed normal behavior. Histological examination showed pronounced infiltration with neutrophils, eosinophils, lymphocytes, and macrophages (Fig. 8) . Table 3 shows the effect of DIDS and phenylglyoxal on the NBT reduction induced by bradykinin. The reduction of NBT was inhibited by 74.3 ± 10.4% by DIDS and by 95.4 ± 2.9% by phenylglyoxal. In each case this inhibition was significantly A: with light microscopy,  the cortex (Cor) leptomeninges and related vessels (V) of the temporal  pole, far removed from the cranial window, appear unremarkable.  250x. Panel B: the area under the window displays conspicuous  leukocyte accumulation (asterisks) within the leptomeninges. 300x  Panel C many of the white blood cells are aligned around blood  vessels (V) entering the brain parenchyma or coursing through the  subarachnoid space. 700x. Panel D: at the electron microscopic level,  the cellular infiltrate shown in panel B is recognized to consist of  neutrophils, macrophages, and 
FIGURE 8. Histological features of brain from a rabbit 24 hours after topical application of arachidonate-Panel
monocytes, as well as occasional degenerating while granular leukocytic profiles (arrows). ZOOOx. Panel E: numerous lymphocytes can also be seen encompassing a venule as well as overlying the cortex (curved arrows) which appears unremarkable. ZOOOx.
different from zero (P < 0.01; paired f-tests). Neither DIDS nor phenylglyoxal affected superoxide production by the xanthine oxidase reaction in vitro. Initial superoxide production rates were 18.8, 18.6, and 17.2 fiM/min per U xanthine oxidase without additives, with DIDS, and with phenylglyoxal, respectively. This finding, with respect to DIDS, confirms the results obtained by Lynch and Fridovich (1978b) . DIDS did not reduce superoxide production 57, No. 1, July 1985 Values are mean ± SE. Total leukocyte counts were 7025 ± 1366 before and 1725 ± 901 cells/mm after administration of antiserum. Neutrophil counts were 5288 ± 1583 before and 1049 ± 952 cells/mm 3 after administration of antiserum.
by activated leukocytes (10.6 vs. 8.0 nM/min per million cells with and without DIDS, respectively). Superoxide production by leukocytes was severely reduced at pH 10; the effect of phenylglyoxal could not, therefore, be tested adequately at this pH.
The initial administration of neutrophil antiserum in dogs induced transient arterial hypotension as described by Romson et al. (1983) . The subsequent injections of antiserum had no hemodynamic effects. Total leukocyte counts were reduced to 25% and neutrophil counts to 20% of the initial control values by the administration of the antiserum. Table  4 showed the bradykinin-induced reduction of NBT in dogs with neutropenia. The average SOD-inhibitable reduction of NBT in these animals was comparable to that seen in response to bradykinin in cats. We also administered the same antibody to three cats. No hemodynamic response was seen in these animals in response to the antibody administration, and no reduction in leukocyte or neutrophil counts occurred. The SOD-inhibitable reduction of NBT in these animals was similar to that seen in cats without pretreatment with antibody.
Discussion
Mechanism of SOD-inhibitable NBT Reduction
These experiments showed the occurrence of SOD-inhibitable reduction of NBT during stimulation of arachidonic acid metabolism from topical application of arachidonate or bradykinin. The most direct explanation for this finding is that NBT is reduced by superoxide anion radical generated concomitantly with the increased arachidonate metabolism. An alternative explanation for the reduction of NBT is that it is due to an unidentified radical (•X) which is capable of reacting reversibly with oxygen to generate superoxide as follows:
• X + O 2 + OJ. SOD, by eliminating superoxide, shifts the equilibrium of this reaction to the right. Hence, in the presence of SOD, the concentration of -X will be reduced and the reduction of NBT will be correspondingly minimized. This will be interpreted as indicating the occurrence of superoxide-mediated reduction of NBT. Winterboum (1981) suggested a means for identifying this indirect mechanism. She found that the concentration of SOD required to inhibit cytochrome c reduction was far greater when such an indirect mechanism was responsible for the reduction rather than when superoxide itself was the mediator. Since, in our experiments (Fig. 5) , the concentrations of SOD required to inhibit NBT reduction were equally effective when the reduction was initiated by arachidonate or bradykinin as they were when the reduction was induced by xanthine plus xanthine oxidase, an enzymic system known to generate superoxide, we conclude that we are dealing with superoxide and not with another unidentified radical.
It is clear from our results that no superoxide enters cerebral extracellular space under resting conditions. Superoxide appeared only when arachidonate metabolism was accelerated.
Generation of Superoxide Anion Radical from Arachidonate Metabolism
Since indomethacin inhibited the reduction of NBT to the same extent as SOD, we conclude that superoxide anion radical originated from the metabolism of arachidonate via cyclooxygenase. This is consistent with earlier studies which showed that vascular injury from topical application of arachidonate was inhibited by pretreatment with indomethacin, and by the observation that topical application of PGG2 induced cerebral vascular injury . Evidence for the production of free radicals from arachidonate metabolism via cyclooxygenase derives from electron spin resonance (ESR) studies and from the use of radical scavengers. Egan et al. (1979) found that during the metabolism of PGG 2 by prostaglandin hydroperoxidase from vesicular microsomal fractions an ESR signal was generated. This was ascribed to the production of a powerful unidentified oxygen radical which was responsible for the inactivation of cyclooxygenase. This signal was subsequently reinterpreted by Kalyanaraman and his colleagues (1982) as originating from the formation of a radical due to oxidation of amino acids near the iron of the heme of cyclooxygenase. Interpretation of the ESR evidence, however, is complicated further by the fact that Egan et al. (1981) found subsequently that the ESR signal they had observed before was no longer present when purified cyclooxygenase was used. They therefore concluded that this signal was due to the adventitious oxidation of endogenous material isolated together with cyclooxygenase. Clearly, more evidence is necessary to interpret the ESR evidence correctly.
There is indirect evidence suggesting the production of superoxide anion radical from cyclooxygenase activity. Marnett et al. (1974) found that SOD inhibited the spontaneous chemiluminescence observed during the incubation of polyunsaturated fatty acids with microsomal fractions from sheep vesicular glands. This chemiluminescence was ascribed to the cyclooxygenase reaction since it was inhibited by indomethacin. Similarly, O'Brien and Hulett (1980) found that luminol-dependent chemi-149 luminescence associated with the reaction between vesicular gland microsomes and arachidonic acid was also inhibited by SOD. It seems, however, that superoxide anion radical is not a direct product of the cyclooxygenase and hydroperoxidase reactions. Marnett et al. (1975) found that the action of prostaglandin hydroperoxidase did not reduce NBT or cytochrome c. Also, SOD did not inhibit prostaglandin production.
The most likely mechanism for superoxide anion production from arachidonate metabolism is an indirect one. It is known that the prostaglandin hydroperoxidase oxidizes a large number of compounds (Marnett et al., 1975 (Marnett et al., , 1979 (Marnett et al., , 1982 Egan et al., 1979 Egan et al., , 1980 Egan et al., , 1981 Mamett and Bienkowski, 1980; Zensen et al., 1980) . It has been shown that these oxidations follow chain reactions involving free radical generation (Egan et al., 1979; Marnett et al., 1979) . In some cases, the reducing cosubstrates have been shown to protect the cyclooxygenase from deactivation, presumably by tying up the destructive radical responsible for deactivation (Egan et al., 1979) . These oxidations provide a possible mechanism for the indirect generation of superoxide anion radical from the reaction with oxygen of one of the radicals produced by the oxidations of substrate. Such a mechanism finds precedent in the action of peroxidases. The initial reaction of peroxidases with hydroperoxy acids is known to generate enzyme-centered radical species Yamazaki, 1965, 1977; Dunford, 1979) . These intermediates react with NADH to form the radical •NAD. This radical, in turn/is known to react with oxygen to produce superoxide Yamazaki, 1965, 1977; Land and Swallow, 1971) .
It is obvious that the generation of superoxide by such a mechanism would depend on the presence of suitable substrates. Since, in isolated enzyme systems, the spatial relationships of various substrates to the prostaglandin hydroperoxidase, as well as their availability, is not the same as in the cell, the absence of formation of superoxide in such systems does not exclude the production of superoxide in an intact cellular environment.
Mechanism of Exit of Superoxide Anion Radical into Cerebral Extracellular Space
Since NBT is a hydrophilic substance and SOD is a high molecular weight compound, neither is likely to enter into cells with ease. Furthermore, the inhibition of NBT reduction by indomethacin shows that superoxide is generated enzymatically in association with the degradation of arachidonate by cyclooxygenase. Hence, it must be produced intracellularly. One must, therefore, conclude that superoxide, following its generation, emerges from the intracellular compartment and enters the extracellular space of the brain where it reduces NBT.
There are several mechanisms by which this can be accomplished. The first is that cells may be injured by the topical application of bradykiriin and arachidonate. The injury may render them permea-ble, in effect removing any barrier to the movement of NBT, SOD, and superoxide from intracellular to extracellular compartment and vice versa. We excluded this mechanism by showing that in the presence of NBT there is no evidence for brain parenchymal cellular damage or injury to the endothelium or vascular smooth muscle. We found in earlier experiments that topical application of arachidonate or PGG 2 caused vascular injury which was inhibited by oxygen radical scavengers . We also found that the vascular injury seen after experimental brain injury was inhibited by NBT . The absence of vascular injury in the present experiments is therefore attributable to the use of NBT which scavenges the injurious radicals.
A second mechanism is that superoxide is generated by cells, such as leukocytes, which normally secrete superoxide into the extracellular environment. The number of leukocytes found in the brain in our experiments on cats and rabbits, however, is totally inadequate to explain the amounts of superoxide produced in the initial stages following application of arachidonate or bradykinin. Also, superoxide production could still be demonstrated in response to topical application of bradykinin in dogs following severe reduction of leukocyte and neutrophil counts. Finally, DIDS inhibited the appearance of superoxide in cerebral extracellular space during bradykinin application, but did not affect superoxide production by activated leukocytes. However, in experiments in which observations were made in rabbits 24 hours after application of arachidonate, a large number of leukocytes were seen invading the vessels, the meninges, and the brain at the site of application of arachidonate. At this later time, it is possible that leukocytes may be a potential source of superoxide.
A third mechanism is that superoxide following its generation emerges from the interior of cells via existing membrane channels. Our finding that two specific inhibitors of the anion channel inhibited the reduction of NBT caused by bradykinin supports this explanation. Fridovich (1978a, 1978b ) generated superoxide anion radical from the xanthine oxidase reaction inside vesicles obtained from red cell membranes. They found that superoxide was capable of traversing the red cell membrane with surprising ease, as indicated by the fact that it could reduce cytochrome c placed outside the vesicles. They also discovered that superoxide could traverse the red cell membrane in the other direction. The exit of superoxide from such vesicles was reduced by inhibitors of the anion channel.
Functional Implications
Since the concentration of SOD in extracellular fluid is considerably lower than in intracellular fluid (Marklund, 1980; Marklund et al., 1982) , it is obvious that superoxide anion radical which enters the extracellular space may survive for relatively longer Circulation Research/Vol. 57, No. 1, July 1985 periods of time than it would had it been retained in the interior of cells. It is therefore more likely to have effects on either blood vessels or on the neural parenchyma. Furthermore, the spontaneous dismutation of superoxide yields hydrogen peroxide. In the presence of catalytic iron, these two radicals may generate hydroxyl radical (McCord and Day, 1978) , which would be expected to be much more destructive to tissue. The ability of superoxide released into the extracellular space to have functional consequences has been demonstrated during topical application on the brain surface of bradykinin (0.1-10 Mg/ml) or arachidonate (50-200 fig/mi ). We found that SOD and catalase inhibited markedly the vasodilator effect of these agents, indicating that superoxide and hydrogen peroxide, or radicals derived from them, are responsible for the observed vasodilation (Kontos et al., 1984) .
The appearance of superoxide in the cerebral extracellular space explains why relatively small amounts of exogenous SOD have a pronounced inhibitory effect on vascular responses attributable to this radical during topical application of bradykinin or arachidonate (Kontos et al., ,1984 and after experimental brain injury or acute arterial hypertension . Also explained is the finding that superoxide in these situations has pronounced functional effects despite the relatively high intracellular concentration of SOD. Had the radical been in the intracellular space, it would have been eliminated fairly quickly by the endogenous scavenging mechanisms.
